logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

ARIAD Pharmaceuticals Inc.

ARIAD Pharmaceuticals Inc. (ARIA)

Follow

Details

Wall

Profile


Ariad Pharmaceuticals Inc is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.

Issuer Information

Exchange: NASDAQ
Market Cap: 3651332094
CEO: Harvey J. Berger
Employees: 300
Issuer Type: CS
Auditor: Deloitte & Touche LLP
Last Audit: UQ
CIK: 884731
Sector: Healthcare
Industry: Biotechnology
Sub-Industry: Biotechnology
NAICS: Biological Product (except Diagnostic) Manufacturin (325414)
SIC: 2836
Last earning call url:
Slideshare slide url:

Contact Information

Main phone: +1 617 494-0400
Address: 26 Landsdowne Street
Address 2:
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02139-4234
Fax:

Videos

No public videos available.

Blog

No Result Found.

News

ARIAD Pharmaceuticals Inc. ($ARIA) was among the biggest gainers on the Russell 2000 for October 20 as the stock popped 6.62% to $5.80, representing a gain of $0.36 per share.…
ARIAD Pharmaceuticals Inc. (ARIA) was among the biggest gainers on the Russell 2000 for October 15 as the stock popped 6.20% to $5.48, representing a gain of $0.32 per share.…
ARIAD Pharmaceuticals Inc. (ARIA) was one of the Russell 2000's biggest losers for October 10 as the stock slid 7.89% to $5.02, a loss of $0.43 per share. Starting at…
ARIAD Pharmaceuticals Inc. (ARIA) was one of the Russell 2000's biggest losers for October 6 as the stock slid 5.74% to $5.42, a loss of $0.33 per share. Starting at…
ARIAD Pharmaceuticals Inc. (ARIA) was one of the Russell 2000's biggest losers for September 30 as the stock slid 6.57% to $5.40, a loss of $0.38 per share. Starting at…
ARIAD Pharmaceuticals Inc. (ARIA) was among the biggest gainers on the Russell 2000 for September 26 as the stock popped 5.57% to $5.69, representing a gain of $0.30 per share.…
ARIAD Pharmaceuticals Inc. (ARIA) was among the biggest gainers on the Russell 2000 for August 25 as the stock popped 5.25% to $6.22, representing a gain of $0.31 per share.…
The biotech bull market is not over. That's the judgment of Reni Benjamin of H.C. Wainwright & Co., who predicts high quality data from a broad range of small- and…
Here’s hoping that Hugh M. Cole doesn’t take this personally. On the same day that Ariad Pharmaceuticals (ARIA) announced the promotion of Cole to the position of chief business officer,…
Markets gained Wednesday as economic data appeared to bolster investor confidence. The Dow Jones Industrial Average (DJIA) and S&P 500 opened lower, gained ground into the late morning, declined back…

Trending

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.